Immunome
IMNM
#4888
Rank
A$2.79 B
Marketcap
A$23.70
Share price
-5.54%
Change (1 day)
-17.38%
Change (1 year)

Earnings for Immunome (IMNM)

Earnings in 2026 (TTM): -A$0.4 Billion

According to Immunome's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.34 Billion a decrease over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunome from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.4 Billion17.7%
2025 -A$0.34 Billion46.04%
2024 -A$0.24 Billion434.17%
2023 -A$43.41 Million-22.15%
2022 -A$55.76 Million46.39%
2021 -A$38.09 Million41.63%
2020 -A$26.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-42.27%๐Ÿ‡บ๐Ÿ‡ธ USA